insider24.ch
Back to the feed

Shareholding disclosure

HBM BioVentures Ltd. Cayman

inBasilea Pharmaceutica AG, Allschwil

Declared position

10.88%

Threshold

Crossed upwards

Timeline

Published

04.01.2008

Transaction

01.12.2007

Transfer date

01.12.2007

Voting rights breakdown

Voting rights acquired10.88%
Voting rights sold0%
Below threshold0%

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T5465D5225

Beneficial owner

HBM BioVentures Ltd. Cayman

Declared address

HBM BioVentures Ltd. (Cayman), George Town, Grand Cayman

Wandel-, Erwerbs- und eingeräumte Veräusserungsrechte Art der Rechte / Anzahl / Damit verbundene Stimmrechte (Anzahl / in %) Call-Option / 17000000 / 212500 / 2,32 / BSLOD SW; ISIN: CH0028814660 Call-Option / 2500000 / 50000 / 0,55 / BSLW SW; ISIN: CH0027968053 Call-Option / 22600000 / 282500 / 3,07 BSLDU SW; ISIN: CH0028814678 Pull-Option / 150000 / 150000 / 1,64 / DB-BSLN (OTC-gehandelt). Emitent: Deutsche Bank; Basiswert: Basilea Pharmaceutica Namenaktien (BSLN); Ratio: 1:1; Strike Price: CHF 240.-; Ablauf: 20 März 2008; Art: European Style Total 997190 / 10,88

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open